Adhesive-Based Sensors for Cancer-Related Lymphedema
Trial Summary
What is the purpose of this trial?
This clinical trial studies how well new adhesive-based sensors that stick to the skin (transcutaneous) work in detecting cancer-related long-term arm swelling (lymphedema). For many patients, lymphedema s painful, unsightly, and weakening. The early signs of lymphedema are hard to see, and sometimes it is only diagnosed by hospital equipment at larger centers. Treating lymphedema early is usually more successful than trying to treat in later stages. The adhesive-based sensors used in this study work by using techniques called photoplethysmography (PPG) and bioimpedance (BI). PPG is an optical technique that can be used to detect blood volume changes in tissue. BI evaluates how tissue responds to an externally applied electrical current. This study may assist researchers in distinguishing participants with lymphedema in comparison to participants without lymphedema, and develop a way for patients to check for lymphedema at home.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on endocrine monotherapy for breast cancer, you can continue with it while participating in the trial.
What data supports the effectiveness of adhesive-based sensors for detecting cancer-related lymphedema?
The research highlights the importance of technology in monitoring lymphedema, with nonwearable sensors being more developed for remote monitoring. Additionally, bioelectrical spectroscopy (BIS) has shown high reliability and validity in assessing limb fluid, suggesting that similar sensor technologies could be effective for lymphedema detection.12345
Is it safe to use adhesive-based sensors for monitoring lymphedema?
How does the adhesive-based sensor treatment for cancer-related lymphedema differ from other treatments?
The adhesive-based sensor treatment for cancer-related lymphedema is unique because it uses wearable sensors to non-invasively monitor the condition, providing real-time data on skin hydration and other physiological signals. This approach is different from traditional treatments that may not offer continuous monitoring or the ability to adapt to wet skin conditions.89101112
Research Team
Carlo M. Contreras, MD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Eligibility Criteria
This trial is for healthy individuals and those with pre-existing lymphedema due to cancer therapy involving surgery or radiation. Participants should have arm swelling needing compression or a significant size difference between arms. Active cancer patients, except breast cancer ones on endocrine monotherapy, can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Diagnostic Assessment
Participants undergo bioimpedance analysis (BIA) and wear 'watch-like' sensors for photoplethysmography (PPG) at rest and while active
Follow-up
Participants are monitored for safety and effectiveness of the sensor technology
Treatment Details
Interventions
- Transcutaneous Sensors
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor